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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

PREIMPLANTATION GENETIC DIAGNOSIS:
DISEASE CONTROL OR CHILD OBJECTIFICATION?

I. INTRODUCTION
With the advances in assisted reproduction technology (ART), parents now
have more choices regarding how and when they start a family. In vitro
fertilization (IVF) has been available for some time now as a way to help
infertile individuals conceive. However, difficulty conceiving is not the only
problem parents may encounter. Some may also face the probability of having
a child afflicted with genetic disease. In the past, amniocentesis1 and chorionic
villous sampling (CVS)2 were performed on fetuses to detect genetic disease or
defects. A new ART technique may make such prenatal diagnostic procedures
unnecessary. This new technique is called preimplantation genetic diagnosis
(PGD) and is one of the latest tools parents may use to prevent genetic defects
in their offspring. Although PGD may help ensure the health of children, there
are concerns that it could be used for purposes other than solely for their
benefit. While discussing the positive aspects of PGD, it is necessary to
consider guarding against the possible exploitation and objectification of
children. This paper will begin by outlining the specifics of the PGD
procedure. The therapeutic uses of PGD will be distinguished from the nontherapeutic uses. The social, ethical and legal questions regarding their
implementation will also be explored. This paper will conclude with a review
of existing international regulation of PGD and recommendations for
legislation in the United States.
II. DESCRIPTION OF PGD
PGD is a diagnostic procedure that is performed before the embryo is
implanted into the woman’s uterus.3 A simplified explanation of PGD may be

1. See STEDMAN’S MEDICAL DICTIONARY 62 (26th ed. 1995) (Amniocentesis is the
ransabdominal aspiration of fluid from the amniotic sac.).
2. See LIFE SCIENCES ONLINE DICTIONARY, at http://biotech.icmb.utexas.edu/search/dictsearch.mhtml, (last visited June 8, 2003) (CVS is the process of taking a biopsy of the placenta,
usually at the end of the second month of pregnancy, to test the fetus for genetic abnormalities
(mutations).).
3. M.A.F. El-Hazmi, Potential Usefulness of Preimplantation Genetic Diagnosis in the
Control and Prevention of Genetic Diseases, 5 E. MEDITERRANEAN HEALTH J. 1134, 1134
(1999).
435
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outlined in three steps: first, several embryos are created using IVF; second,
after reaching a certain stage in development, each embryo DNA is tested for
genetic disease; third, embryos determined to be unaffected by genetic disease
are implanted in the woman’s uterus in hopes of a successful pregnancy.4
Although each step described above is important, the second step (testing for
disease) is crucial to the PGD process. Detecting genetic disease in an embryo
can be very complicated and should be explained more fully.5 First, oocytes6
are recovered by ultrasound-guided aspiration and grown in culture.7 Oocytes
are then subjected to micromanipulation8 and the first polar body9 is
removed.10 The polar body is then biopsied and undergoes genetic diagnosis.11
The oocyte is then injected with sperm for zygote12 formation.13 Next, the
second polar body is removed for genetic diagnosis.14 The zygote is allowed
to grow to a six-to-eight cell stage one or two cells are then removed for

4. This indeed is a simplified explanation of the PGD process. PGD is a very complicated
process requiring expertise in both reproductive and genetic medicine. See Richard J. Tasca &
Michael E. McClure, The Emerging Technology and Application of Preimplantation Diagnosis,
26 J.L. MED. & ETHICS 7, 12-14 (Spring 1998) (The six technologies involved in PGD include
hormonal stimulation, IVF to produce embryos, culture of embryos, biopsy of cells from embryo
or polar body biopsy of unfertilized egg, subjecting cells to genetic analysis and transferring the
unaffected embryos to uterus.); see also W. Lissens et al., Review: Preimplantion Diagnosis of
Inherited Disease, 19 J. INHERITED & METOBOLIC DISEASE, 709, 719 (1996) (“Preimplantation
diagnosis is . . . a procedure requiring the multidisciplinary collaboration of a clinical IVF unit, a
laboratory IVF unit with micromanipulation facilities, a molecular biology and cytogenetics
laboratory, and clinical genetics unit. Most centeres still consider [PGD] an experimental method
and request and advise follow-up prenatal diagnosis in cases of pregnancy.”).
5. For a detailed discussion of PGD, see generally A Practice Committee Report:
Preimplantation Genetic Diagnosis, AM SOC’Y OF REPROD. MED. 1 (June 2001) [hereinafter
ASRM], available at http://www.asrm.org/Media/Practice/Preimplantation.pdf; see also E.
Kanavakis & J. Traeger-Synodinos, Preimplantation Genetic Diagnosis in Clinical Practice, 39
J. MED. GENETICS 7 (Jan. 2002); El-Hazmi, supra note 3, at 1134, 1134-39 (1999).
6. STEDMAN’S MEDICAL DICTIONARY, supra note 1, at 1248 (An oocyte is an “immature
ovum”).
7. El-Hazmi, supra note 3, at 1134.
8. STEDMAN’S MEDICAL DICTIONARY, supra note 1, at 1113 (Micromanipulation is the
“dissection, teasing, stimulation, etc., under the microscope, of minute structures.”).
9. LIFE SCIENCE ONLINE DICTIONARY, supra note 2 (A polar body is a “small cell which is
the product of an uneven division of the cytoplasm during meiosis; the smaller of the two cells
produced during a meiotic division of oogenesis (the larger one becomes an oocyte or ovum). It
eventually degenerates.”).
10. El-Hazmi, supra note 3, at 1134.
11. Id.
12. STEDMAN’S MEDICAL DICTIONARY, supra note 1, at 1976 (A zygote is the “diploid cell
resulting from a union of sperm and ovum.”).
13. El-Hazmi, supra note 3, at 1134.
14. Id.
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genetic analysis.15 Analysis is performed by extracting DNA from the cells
and subjecting it to polymerase chain reaction16 (PCR) or fluorescence in situ
hybridization17 (FISH).18 Although PGD was first performed nearly 13 years
ago19 and has successfully eliminated genetic disease in a number of
children,20 clinical application of PGD has remained limited.21 Several reasons
exist for its slow implementation. First, PGD is a multi-step procedure that
requires combined expertise in reproductive medicine and molecular
genetics.22 Second, genetic diagnosis of cells is challenging at all stages.23
Accuracy problems have become apparent,24 including allelic drop out.25 In
addition to the practical and technical problems with PGD, there are many
social, ethical and legal issues that require further attention and debate. As will
be discussed later, some countries have taken steps to address these concerns,
while others are just beginning.
III. DEMAND FOR PREIMPLANTATION GENETIC DIAGNOSIS
Despite the many questions that surround the use of PGD, demand for the
procedure is increasing.26 Potential uses for PGD can be divided into two
15. Id.
16. LIFE SCIENCE ONLINE DICTIONARY, supra note 2 (PCR is a method used for amplifying
a DNA base sequence using a heat-stable polymerase and two 20-base primers, one
complementary to the (+)-strand at one end of the sequence to be amplified and the other
complementary to the (-)-strand at the other end. Because the newly synthesized DNA strands can
subsequently serve as additional templates for the same primer sequences, successive rounds of
primer annealing, strand elongation, and dissociation produce rapid and highly specific
amplification of the desired sequence. PCR also can be used to detect the existence of the defined
sequence in a DNA sample.).
17. See NATIONAL HUMAN GENOME INSTITUTE GLOSSARY, at http://www.genome.gov/
glossary.cfm (last visited June 8, 2003) (FISH is “a process which vividly paints chromosomes or
portions of chromosomes with fluorescent molecules. This technique is useful for identifying
chromosomal abnormalities and gene mapping.”).
18. See Kanavakis & Traeger-Synodinos, supra note 5, at 6; see also El-Hazmi, supra note
3, at 1134.
19. See El-Hazmi supra note 3, at 1134-35.
20. See e.g., Denise Grady, Baby Spared Mother’s Fate by Genetic Tests as Embryo, N.Y.
TIMES, Feb. 27, 2002, at 16A (PGD used to ensure the absence of gene that causes early onset of
Alzheimer’s in resulting child); see also Lisa M. Krieger, Ferreting Out Flawed Embryos,
MERCURY NEWS, March 12, 2002 (offers several examples of successful uses of PGD).
21. Kanavakis & Traeger-Synodinos, supra note 5, at 6.
22. Id.
23. Id.
24. Id.
25. ASRM, supra note 5, at 1. (Allelic drop out occurs when one of the two alleles
selectively amplifies, thus contributing to diagnostic errors.).
26. See Aaron Zitner, A Girl or Boy, You Pick, L.A. TIMES, July 23, 2002, at 1, at
http://www.latimes.com/la-na-gender23jul23012035.
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groups: therapeutic and nontherapeutic. Therapeutic uses involve utilizing the
procedure to prevent and treat disease in children. Nontherapeutic applications
involve using PGD for superficial or non-medical reasons like selection of
embryos based on gender and physical appearance.
A.

Therapeutic Uses of PGD

There are two types of therapeutic uses for PGD: one, to prevent genetic
disease in future children; and two, to treat disease in existing children.
Parents who are carriers of diseases are often aware of their genetic make-up
and the potential of passing those diseases on to the next generation. PGD can
be used for those who do not wish their children to suffer from genetic disease.
A recent case involved a woman who carried the gene for early onset
Alzheimer’s disease.27 She used PGD to produce a daughter free of the
affected gene.
Other diseases which can be eliminated by using PGD include cystic
fibrosis, Tay Sachs, Marfan’s Syndrome, Duuchenne’s muscular dystrophy,
Fragile X syndrome, sickle cell and Fanconi’s anemia, thalassaemia and
Downs syndrome.28 Normally amniocentesis and chorionic villous sampling
(CVS) are used to detect such diseases and malformation in fetuses. With
those procedures, the woman may consider terminating the pregnancy if the
fetus is found to have a disease or defect. PGD is considered more
advantageous than these prenatal diagnostic methods because diagnosis is
performed before the embryo is implanted in the woman. This way the woman
does not have to face the potential emotional and physical effects of abortion.
The second and more controversial therapeutic use of PGD involves using
the procedure to select a donor match for an existing ill child. It is possible to
choose an embryo that may produce a child who will provide stem cells or
bone marrow for a sibling or other relative. PGD has been used for such
reasons in the United States and England. In 1999, a couple in the United
States used PGD to screen their embryos for one that was a tissue match for
their daughter who had Fanconi’s anemia.29 Five suitable embryos were
implanted in the woman and one resulted in a successful pregnancy. When the
new child was born, birth blood from the umbilical cord was harvested and
used in a successful stem cell transplant for the daughter. In Britain, where the
Human Fertilisation and Embryology Authority must authorize such uses of

27. See Grady, supra note 20, at 16A.
28. See ASRM, supra note 5, at 2; see also Tasca & McClure, supra note 4, at 7.
29. See Lisa Belkin, The Made-to-Order Savior, N.Y. TIMES MAG., July 1, 2001, at 38-39
(describing the experiences of parents using PGD to conceive donor matches for their existing
children).
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PGD, the parents of a 2-year-old boy with beta thalassaemia were given
permission to use PGD to produce a matching donor.30
Although these two therapeutic uses of PGD are employed to ensure the
health of future and existing children, many questions surround their use. Such
concerns include the success rate and reliability of the procedure,
discrimination against the disabled, new eugenics worries, creating a social
divide between those who have access to the procedure and those who do not,
and the ethics of creating a child for donor purposes. All of these concerns
will be addressed in turn.
1. Reliability of PGD
As mentioned above, because it is a technically complicated procedure,
there may be problems with the accuracy of PGD. The overall diagnostic error
rate for PGD is 1.8%.31 In fact, one couple tried to sue the institution where
they underwent PGD because the procedure failed.32 Despite the fact that the
couple had their embryos screened for cystic fibrosis, their daughter was born
with the disease.33 For this reason, the American Society of Reproductive
Medicine (ASRM) recommends that for quality control purposes the diagnosis
of the affected, non-transferred, abnormal embryos be confirmed on additional
blastomeres to ensure the accuracy of the techniques and diagnosis.34 ASRM
further suggests that the normality of implanted embryos be reconfirmed by
subsequent CVS or amniocentesis.35 Potential parents using PGD should be
counseled during the informed consent process that there is a slight chance the
procedure may not work. They should be informed further that if the fetus is
found later to have a disease or defect, the woman may choose to terminate the
pregnancy.
It is also important to note that only diseases selected for screening will be
successfully eliminated by PGD. For instance, if a couple uses PGD to screen
embryos for cystic fibrosis only, the child may still be born with Down’s
syndrome or Fanconi’s anemia, for which the embryos were not screened.
Similarly, the child may still be born with congenital malformations and non-

30. Health, Go-ahead for ‘Designer’ Baby, BBC NEWS, Feb. 22, 2003, at
http://news.bbc.co.uk/1/low/health/1836827.stm.
31. See Editorial, Preimplantation Donor Selection, 358 LANCET 1195 (Oct. 13, 2001).
32. Doe v. Illinois Masonic Med. Ctr., 696 N.E. 2d 707 (Ill. App. Ct. 1998) (resulting child
was born with Cystic Fibrosis even after PGD was used to screen for the disease).
33. Id.
34. ASRM, supra note 5, at 2.
35. Id.
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genetic diseases that PGD cannot detect.36 Parents should be made aware of
these possibilities and counseled before and after undergoing the procedure.
2. Discrimination Against the Disabled
Considered to be a therapeutic procedure, PGD has been called an
“effective and compassionate” way to prevent suffering of future children.37
However, there is opposition to PGD being used to identify and discard
embryos affected by genetic disease.38 Some advocates for the disabled argue
that using PGD will increase intolerance and discrimination against those with
disabilities and those afflicted with genetic diseases. 39 “As society focuses on
improving the human race, compassion for the disabled may decrease to
traumatic levels affording less appreciation for differences between
individuals.”40 This statement assumes that improving the human race means
eliminating individuals instead of disease.
Others disagree that choosing to discard diseased embryos will result in
“intolerance, aversion or disdain for disabled life” and find a difference
between genetic selection and discrimination against the disabled.41 They
point out that many disabled people lead active productive lives and thrive in
society. It is argued that these individuals should not be denied any right or
aspect of life. However, it should not be assumed that all disabled or ill people
share the same positive outlook or are able to appreciate life in the same way.42
There are also disabled people who have no cognitive ability or are unable to
understand their situation. “Reality proves that, in the worst circumstances,
life brings some disabled children only pain, hopelessness, and bodily
36. See Jeffrey Botkin, Ethical Issues and Practical Problems in Preimplantation Genetic
Diagnosis, 26 J.L. MED. & ETHICS 17, 18 (1998) (“PGD is not useful for predicting congenital
malformations or diseases that do not have an identified genetic basis.”).
37. Megan Anne Jellinek, Note, Disease Prevention and the Genetic Revolution: Defining a
Parental Right to Protect the Bodily Integrity of Future Children, 27 HASTINGS CONST. L.Q. 369,
371 (2000).
38. See David S. King, Preimplantation Genetic Diagnosis and the “New” Eugenics, 25 J.
MED. ETHICS 176 (1999).
39. See Renee C. Esfandiary, Note, The Changing World of Genetics and Abortion: Why the
Women’s Movement Should Advocate for Limitation on the Right to Choose in the Area of
Genetic Technology, 4 WM. & MARY J. WOMEN & L. 499, 499 (1998); see Martha A. Field,
Killing “the Handicapped”—Before and After Birth, 16 HARV. WOMEN’S L.J. 79 (1993)
(discussing the woman’s right to terminate a pregnancy upon discovering a defect in the fetus and
the parental right to refuse medical treatment of a new born affected by disease).
40. Esfandiary, supra note 39, at 499.
41. See Jellinek, supra note 37, at 390; see also Botkin, supra note 36, at 23 (“Current
experience indicates that society can simultaneously promote respect and opportunity for the
disabled while enabling couples to prevent the birth of a disabled child through prenatal
diagnosis.”).
42. This is supported by the on going debate over right-to-die issues.
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degradation”.43 PGD may offer parents a way to prevent “needless suffering”
in their future children.44
In addition, since parents have been afforded discretion in health matters at
all stages of a child’s development, they may also have the right to intervene at
the embryonic level. For example, parents may use amniocentesis and
chorionic villous sampling to determine the health of a fetus. If problems are
found, women may choose to terminate pregnancy before viability of the
fetus.45 Furthermore, when a newborn is found to have a debilitating disease,
parents may sometimes choose to cease nourishment or forego life-saving
treatment allowing the child to die.46 In some instances parents may also
choose to forego life support for minor children.47 The ability of parents to
make end-of-life decisions for their children has been considered by Florida
courts:
[D]ecisions of this character have traditionally been made within the privacy of
the family relationship based on competent medical advice and consultation by
the family with their religious advisors, if that be their persuasion.48

Since parents have the right to protect the bodily integrity of future and
existing children at the fetal and post birth stages, it would seem parents should
also have the power to do so at the embryonic level.49
However, should parents have total control at the embryonic level? What
if they want to use PGD to purposely create a child with a genetic defect?
Although there have been no such reported cases, one hypothetical is a deaf

43. Jellinek, supra note 37, at 391.
44. Id. at 394.
45. See June Coleman, Note, Playing God or Playing Scientist: A Constitutional Analysis of
State Laws Banning Embryological Procedures, 27 PAC. L.J. 1331, 1346 (1996).
46. See James Bopp, Jr. & Mary Nimz, A Legal Analysis of the Child Abuse Amendments of
1984, in COMPELLING COMPASSION: GOVERNMENT INTERVENTION IN THE TREATMENT OF
CRITICALLY ILL NEWBORNS 73-103 (Arthur L. Caplan, et al., eds., 1992); but see 45 C.F.R. §
1340.15(2)(i-iii) (Treatment may only be withheld if the infant is chronically and irreversibly
comatose, treatment would merely prolong dying, or the treatment would be futile.); see also
HCA, Inc. v. Miller, 36 S.W.3d 187, 194 (Tex. App. 2000) (Parents did not have a common law
right to withhold treatment from a child who was not terminally ill.).
47. See Ann MacLean Masssie, Withdraw of Treatment for Minors in a Persistent Vegetative
State: Parents Should Decide, 35 ARIZ. L. REV. 173, 176 (1993).
48. In re Barry, 445 So. 2d. 365, 371 (Fla. Dist. Ct. App. 1984).
49. See Jellinek, supra note 37, at 387 (“Unlike the limits on reproductive rights, the right to
protect children’s bodily dignity is more thoroughly grounded in fundamental rights doctrine and,
therefore, provides a more trustworthy means of protecting parental discretion in making difficult
procreative choices.”).
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couple using PGD to select an embryo that will develop into a deaf child.50 A
gene for deafness has been identified,51 making it possible to use PGD for this
purpose. Couples have used other ART methods to purposely increase their
chances of having deaf children. A deaf couple in the United States, used a
sperm donor who was totally deaf and had five generations of deafness in his
family.52 Ms. Duscheneau, the expecting mother, explained her position on
creating a deaf child as follows, “A hearing baby would be a blessing. A deaf
baby would be a special blessing.”53 In 2001, Ms. Duscheneau’s child, Gauvin
McCullough, was born with only a slight amount of hearing in one ear.54
PGD may be used to accomplish the same goal of having a deaf child. To
some critics, intentionally selecting an embryo that will develop into a deaf
child may seem unnecessary and of more benefit to the parent than the child.
Some may see it as worse than unnecessary - as affirmatively harmful.
But how should harm be defined? What if a parent or physician does not
consider deafness to be harmful or to be a disability? This question cannot be
asked in terms of other diseases such as cystic fibrosis, Fanconi anemia or TaySachs. Pain and death are associated with these diseases, whereas deaf people
are capable of living long and happy lives. This issue relates back to the
discussion regarding diversity and tolerance of others. Parents often discover
birth defects using CVS or amniocentesis prior to delivery, then decide to carry
the pregnancy to term anyway, and raise the child. Is this any different from
selecting a diseased embryo for implantation, carrying the pregnancy to term,
and raising the child?
However, it seems that if the law allows individuals to sue physicians or
institutions that have caused their deafness,55 deafness may be viewed as a
disability most of society would choose to avoid. There also may be
disadvantages to being deaf in terms of education, with the need of translators

50. See Stephanie Adamson, Genetics and Assisted Reproduction Survey (1998) available at
http://www.dartmouth.edu/~cbbc/courses/bio4/bio4-1998/StephanieSurvey.html (last visited June
8, 2003).
51. See Nonsyndromic Deafness DFNA1 Associated with Homolog of the Dorsophila Gene
diaphanous, GENETIC SCIENCE LEARNING CENTER (on file with the author).
52. See Couple “Choose” to Have a Deaf Baby, BBC NEWS, Apr. 8, 2002, at
http://news.bbc.co.uk/1/hi/health/1916462.stm (last visited June 8, 2003).
53. Liza Mundy, A World of Their Own; In the Eyes of His Parents, If Gauvin Hughes
McCullough Turns Out to be Deaf, That Will Be Just Perfect, WASH. POST, Mar. 31, 2002, at
W22.
54. Couple ‘Choose’ to Have a Deaf Baby, supra note 52 (The couple says they will allow
the child to decide if he wants to wear hearing aids when he is older).
55. See United States v. Kubrick, 444 U.S. 111 (1979) (A veteran who received treatment at
VA hospital that resulted in his deafness would have had a claim had he met the statute of
limitations requirements.).
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and possibly special schools.56 To some it may seem unethical to allow
parents to choose a trait in a child that is treated by society as a disability or
disadvantage.57
3. The Social Divide
Besides discrimination against the disabled, there exists another social
concern surrounding the therapeutic use of PGD for future children. The cost
of PGD may prevent less financially secure families from access to the
procedure. It has been reported that the PGD procedure can cost $15,000 to
$20,000.58 At that cost, only wealthy families may be able to use PGD to
prevent disease in future children.59 This may create a greater social divide
where the rich suffer from fewer diseases and the poor are identified by a
higher incidence of genetic defect.
There are also concerns that those who do not use PGD will face higher
health insurance costs for their children. A time may come when insurance
companies offer a discounted price for those who underwent PGD screening.
More troubling is the possibility that instead of merely offering a benefit to
those who underwent PGD, insurance companies will start penalizing those
who procreate without submitting to PGD. Of course these concerns are all
speculative for the moment. However, it is never too early to consider
legislation preventing insurance companies from creating a greater divide
between those who are able afford coverage and those who are not.
A divide may also develop between countries. When a change in a country
causes a shift from poverty to a stronger economy, the health needs of its
citizens also shift.60 Countries in which starvation was once the main health
concern may suddenly face a pattern of diseases that occur later in a person’s
life. Blood diseases such as sickle cell anemia and thalassaemias have become

56. See Mundy, supra note 53.
57. However, some in society may also consider being female or a racial minority a
disadvantage. This does not mean that parents should be able to discard embryos merely for
these reasons.
58. See Krieger, supra note 20; cf. Botkin, supra note 36, at 18 (“In a 1997 publication,
Bradley Van Voorhis, et. al., calculate the cost per delivery of IVF in 71 couples to be $43,000
per delivery of an infant.”).
59. See Vicki G. Norton, Comment, Unnatural Selection: Nontherapeutic Preimplantion
Genetic Screening and Proposed Legislation, 41 UCLA L. REV. 1581, 1598 (1994) (“It appears
that current costs are prohibitive even for therapeutic preimplantation screening . . . . According
to Director Joseph D. Schuman [of the Genetics and IVF Institute in Fairfax, Virginia] couples
who have inquired about the procedure have been deterred by the cost and lack of insurance
coverage for the procedure.”).
60. See WORLD HEALTH ORGANIZATION, GENOMICS AND WORLD HEALTH: REPORT ON
THE ADVISORY COMMITTEE ON HEALTH RESEARCH §3.2 (2002).
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more prevalent in countries going through such demographic transition.61
Although a country’s medical needs may change, its ability to meet those
needs may not.62 A rapid increase in disease may outpace a country’s access to
new technology required to counter health problems. If disease prevention
methods, such as PGD, are not readily available in these countries, the
incidence of genetic disease will be higher than that of more developed nations
with better access to advanced medical technologies.
4. Using PGD to Create a Child-Donor for an Existing Sibling
As mentioned above, parents may use PGD not only to prevent disease in
future children, but also to benefit existing ill children. In a 2000 meeting,
ASRM considered such uses of PGD and concluded that the procedure was
justified.63 Since parents have an affirmative right to procreate and may
consent to a child being used as a tissue donor, they may conceive a second
child in hopes of creating a match for the sick sibling. Parents have used a
wide range of conception methods, from PGD to natural coitus, to create
children who will provide matching stem cells or bone marrow.64
In the Ayala case, the parents of a young girl suffering from chronic
myelogenous leukemia conceived another child through natural coitus in the
hopes that it would be a compatible bone marrow donor.65 When selecting to
produce a donor through natural coitus, parents are not certain if the new child
will be a tissue-type match. In the Ayala case, the new child was a match and
the procedure was a success,66 but some parents may wish to eliminate some of
the uncertainty when trying to produce a suitable donor match. With PGD, the
embryos can be screened before implanting them into the woman’s uterus, thus
eliminating most uncertainty.

61. See id. §5.2.1.
62. See id. at §3.2
The evolution of thalassaemia in Cyprus is a good example. This condition was not
identified in the island until 1944, when, after a major malaria eradication programme and
accompanying improvements in public health, it became clear that among the children
there was a common form of anaemia which was later identified as thalassaemia. By the
early 1970s it was estimated that, if no steps were taken to control the disease, in about 40
years time the blood required to treat all the severely ill affected children would amount to
78,000 units per annum, 40% of the population would have to be blood donors, and the
total cost of managing the disease would equal or exceed the Island’s health budget.
63. Robert J. Boyle & Julian Savulescu, Ethics of Using Preimplantation Genetic Diagnosis
to Select a Stem Cell Donor for an Existing Person, 323 BRIT. MED. J. 1240, 1241 (2001).
64. See Belkin, supra note 29.
65. See Sally Ann Stewart, Toddler May Be Sister’s Lifesaver, USA TODAY, June 4, 1991, at
3A; see also Boyle & Savulescu, supra note 63, at 1240 (The Ayala case: parents conceived a
child in order to provide stem cells for sibling.).
66. See Boyle & Savulescu, supra note 63, at 1240.
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Commentators have criticized the creation of a child for donor purposes as
an unethical reason for having children and as an immoral objectification of
the child.67 There are worries that the child will not be valued beyond its role
as a donor. The child is essentially being brought into the world to benefit the
existing members of the family, not necessarily because he or she is a desired
addition to the family. Some critics have described creating children to
provide stem cells as “using an unborn child as a commodity.”68
Supporters of PGD counter this argument by stating that many children are
born for a particular purpose, whether it is to care for their parents, as a
companion to a sibling or to run a family business.69 Advocates of PGD also
argue that it is more unethical not to use the procedure when a life of another
child can be saved.70 Another criticism of creating a donor through PGD stems
from the psychological effects it may have on the donor child. This differs
from the post-traumatic stress syndrome71 that some child or adult donors may
go through. In contrast, PGD created children will not remember the
procedure. Rather, PGD children could be harmed by the later knowledge that
they were conceived primarily for their tissue harvested at birth. Such theories
of psychological harm have been dismissed as “unpredictable, unlikely to
occur, and even if [occurring], unlikely to be so severe that it would be better
for that particular child never to have existed.”72 It has also been argued that it
is difficult to claim that being born for a particular reason is against a child’s
best interest, or inflicts harm on that child.73 It cannot be said that a child
whose conception was motivated by the need to produce a donor is harmed,
because the alternative for that child is to never have been born.74 Others even

67. See Stephanie J. Hong, And “Cloning” Makes Three: A Constitutional Comparison
Between Cloning and Other Assisted Reproductive Technologies, 26 HASTINGS CONST. L.Q. 741,
780 (1999) (“There are, however, some commodification-objectification concerns in creating a
child simply to produce an organ or tissue donor.”).
68. See Boyle & Savulescu, supra note 63, at 1241.
69. Id.
70. See Belkin, supra note 29, at 40 (Dr. John Wagner argues that it is “indefensible” not try
to save a dying child when you have the capability).
71. See Cara Cheyett, Note, Organ Harvests from the Legally Incompetent: An Argument
Against Compelled Altruism, 41 B.C. L. REV. 465, 477 (2000) (“Fully one-third of children
whose siblings were bone marrow recipients suffered from signs of post traumatic stress
syndrome.”).
72. Boyle & Savulescu, supra note 63, at 1240.
73. Michael T. Morley, Note, Proxy Consent to Organ Donation by Incompetents, 111 YALE
L.J. 1215, 1223 (2002).
74. Boyle & Savulescu, supra note 63, at 1240.
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argue that due to the intense bonding that can occur between siblings there are
psychological benefits, not harm, to tissue donation.75
While these are intriguing points from supporters of PGD, using the
procedure to produce a donor should not be advocated lightly. Physicians
should develop protocols to ensure that children created by using PGD are
valued as individuals and not mere tissue donors. First, doctors should ensure
that there are no other treatments available for the existing child. This includes
ensuring that there are no available adult donors. Second, doctors should only
perform the procedure for families indicating they desire more children.76
Third, the family should be counseled on the success rate of the procedure.
They should be reminded that PGD is a complicated procedure involving six
separate technologies, each complex and subject to technical errors.77 The
parents should be prepared not only for the possibility that the child may still
be born with the disease for which it was screened,78 but that it could be born
with other diseases for which it was not screened.79 Fourth, the parents should
be counseled on the possible psychological effects on the donor child. Finally,
the family should agree to periodic follow up counseling sessions to monitor
the family’s adjustment after the procedure.
The medical community has also considered the possibility that parents
will use PGD and then decide to abort the fetus once it reaches the stage at
which the desired tissue or “cord blood can be retrieved.”80 Although labeled
an “extreme speculation,”81 the possibility of aborting a fetus after harvesting
donor tissue remains a constant issue in the discussion of using PGD to help an
existing child.82

75. Peter Browett & Stephen Palmer, Altruism by Proxy: Volunteering Children for Bone
Marrow Donation: Legal Barriers Might Have Catastrophic Effects, 312 BRIT. MED. J. 242
(1996).
76. See Belkin, supra note 29, at 40 (Dr. Mark Hughes proposed such a requirement on
parents wishing to use PGD to save an existing child.).
77. See Tasca & McClure, supra note 4, at 12; see text accompanying note 4.
78. Doe v. Illinois Masonic Med. Ctr., 696 N.E.2d 707 (Ill. App. Ct. 1998) (resulting child
was born with Cystic Fibrosis even after PGD was used to screen for the disease).
79. See Botkin, supra note 36, at 19.
80. LANCET, supra note 31, at 1195.
81. Id.
82. See Belkin, supra note 29, at 40
The author asks, “If society gives its blessing to the use of one child to save another, then
what would prevent couples from someday going through with the process but aborting
when the pregnancy was far enough along that the cord blood could be retrieved? Or
what would prevent couples whose child needed a new kidney from waiting until the fetal
kidney was large enough, then terminating pregnancy and salvaging the organs?”.
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While a woman may terminate a pregnancy for any reason up to the point
of viability,83 state laws prohibiting experimentation on fetuses may prevent
women from aborting fetuses to retrieve tissue needed to save an existing
child.84 Within Florida’s abortion statute is a provision that bans
experimentation on fetuses:
No person shall use any live fetus or live, premature infant for any type of
scientific, research, laboratory, or other kind of experimentation either prior to
or subsequent to any termination of pregnancy procedure except as necessary
to protect or preserve the life and health of such fetus or premature infant.85

Since PGD involves human subjects and the technology is considered “new” or
“experimental,” it may be classified as research.86 If the step of collecting
tissue samples or cord blood from the fetus, subsequent to termination were
considered a part of the experimental PGD process, Florida law would then
prohibit the practice. However, it is unclear what is meant by the phrase “live
fetus.” If the harvesting of the needed blood cells or tissue is conducted on a
fetus that is no longer “live” immediately after termination, the procedure may
be permissible. It is also interesting to consider what the outcome would be if
the fetus is determined to be dead within the womb. Arguably, it could be
permissible to collect the needed blood cells or tissue in that situation since the
fetus is no longer “live.”
B.

Nontherapeutic Uses of PGD

PGD can also be used for nontherapeutic reasons, some of which may be
superficial. It is not always clear what reasons should be defined as
nontherapeutic and superficial. Do they go beyond hair and eye color? Should
I.Q. be included? For the purposes of this paper nontherapeutic uses of PGD

83.
84.
85.
86.

See Planned Parenthood v. Casey, 505 U.S. 833 (1992).
See FLA. STAT. ANN. § 390.0111(6) (2001).
Id.
See NAT’L COMM’N FOR THE PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL AND
BEHAVIORAL RESEARCH, THE BELMONT REPORT: ETHICAL PRINCIPLES AND GUIDELINES FOR
THE PROTECTION OF HUMAN SUBJECTS OF RESEARCH, Part A (1979) (“Experimental” does not
always make a procedure “research,” but new procedures should be the object of formal research
at an early stage to determine if it is safe.); see also ASRM, supra note 4, at 5 (“Procedure for the
treatment of infertility is considered experimental until there is scientific evidence indicating
safety and efficacy.”); see also THE NEW YORK TASK FORCE ON LIFE AND THE LAW, ASSISTED
REPRODUCTIVE TECHNOLOGIES: ANALYSIS AND RECOMMENDATION FOR PUBLIC POLICY, 223
(1998) (Standards are generally stricter in cases involving experimental treatments, both because
the risks to the patient may not be known and because the physician, as researcher, may not be
motivated solely by the patient’s best interests.); see also Karin Morin, The Standard of
Disclosure in Human Subject Experimentation, 19 J. LEGAL MED. 157, 167 (1998) (Innovative
therapies should be conducted as research.).
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will be divided into three categories.87 The first category consists of selection
based on cosmetic traits, associated with the physical appearance of an
individual (hair and eye color). The second includes selection based on
performance traits, concerning a person’s skills and aptitudes (I.Q. and musical
ability). The third category involves selection based on gender/sex traits,
relating to an individual’s sexual identification and possibly sexual
orientation88 (male or female, heterosexual or homosexual).89
1. Cosmetic Selection
The first category, cosmetic selection, may be compared to racial
discrimination. Racial discrimination is prejudice against a person based on
outward appearance, including skin color, hair color, eye color and physical
build.90 If it is both morally and legally objectionable to discriminate against
someone due to skin color, it may be just as unacceptable to discriminate
against someone based on superficial traits like hair and eye color. However,
whether it should be unacceptable depends on the reasoning for outlawing
racial discrimination.91 If the purpose of the law prohibiting discrimination is
to protect a “discrete and insular” minority,92 then discrimination based on
nonracial cosmetic traits may be permitted. Certain groups of people may not
be considered discrete and insular just for having specific cosmetic traits. On
the other hand, if the reason for preventing racial discrimination is grounded in
the idea that a person should not be judged by traits that have nothing to do
with ability, then it follows that a person should not be discriminated against
based on cosmetic traits.93

87. Norton, supra note 59, at 1604-06 (The first two of the categories used here are based on
those mentioned by Norton.).
88. Although a “gay gene” has not been discovered, scientists have been unable to invalidate
the idea that genetics influence sexual orientation. See Erica Goode, Study Questions Gene
Influences on Male Homosexuality, N.Y. TIMES, Apr. 23, 1999, at A18; see also Rick Weiss,
Research Casts Doubt on “Gay Gene” Theory; Study Finds Nothing Within X Chromosome That
Predicts Male Homosexuality, WASH. POST, Apr. 23, 1999, at A12 (Both articles report that a
team of researchers were unable to confirm a study linking male homosexuality to “gay gene.”).
89. Gender traits fall outside the category of cosmetic traits because sex identification cannot
always be based on physical appearance. In addition, there are issues of gender equality and
homophobia that are more easily addressed if gender and sexual orientation selection occupy a
separate category.
90. Norton, supra note 59, at 1607.
91. Id. at 1607-08.
92. See United States v. Carolene Prod., 304 U.S. 144, 152 n.4 (1938).
93. Here discrimination against people is being analogized with discrimination against
embryos. It should be noted that in most cases embryos are not given the same constitutional
status as people, making this analogy invalid.
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Parents who use PGD to select for specific physical traits should be
reminded that the procedure sometimes fails. They may feel disappointed if
they do not get the blond hair, blue-eyed bundle of joy they ordered.
Furthermore, even if the procedure is a success, the child may later choose to
change his or her appearance. PGD may enable parents to select traits at the
genetic level, but it cannot control the environment into which the child is
born.
Parents should be counseled on possible unrealistic behavior
expectations placed on children selected for certain physical traits. Since
environment also has an impact on a child’s development and personality,
selecting a child based on physicality may not always result in the family
parents envisioned.
2. Performance Traits Selection
It may be more difficult to argue against using PGD for the second
category, performance traits. We allow discrimination against naturally born
persons who do not fulfill certain ability or aptitude requirements.94 This is an
accepted form of discrimination because many in the United States subscribe
to the theory that those who occupy the low end of nature’s bell curve are
necessary to the functions of society. This is the classic capitalist view of
society. So, for example, if parents have the economic means they may use
PGD to produce the musical prodigy they always wanted.
As previously mentioned, however, PGD cannot control the environment
in which a child is born. The child could have other influences besides the
parents, leading to a passion for something besides music. With this
possibility, it is important that children not be exploited to attain the goals and
interests of their parents. There needs to be a balance between the interest in
preventing the exploitation of children and the harm in not allowing parents to
select an “ideal” child.95 While preventing parents from using PGD to select a
child based on performance traits may inhibit their procreative freedom, caring
for a normal child would cause no greater cost than caring for a gifted child.
However, the expectations placed on an “ideal” child may cause psychological
or self esteem issues. Therefore, the interest in protecting the child outweighs
the parents’ desire to select a child based on performance traits. For this
reason, using PGD to select children based on performance traits should not be
permitted.
Furthermore, allowing parents to select children based on performance
traits again raises questions regarding the social divide. If only the wealthy are

94. Examples include employers who hire based on speed typing skills, schools that reject
students based on SAT or LSAT scores, and art institutions that pass over individuals considered
to lack talent.
95. Norton, supra note 59, at 1608.
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able to use PGD to select children with the best performance traits, those who
are less financially secure are placed at yet another disadvantage. Although
speculative at this point, it is foreseeable that only offspring of the wealthy
would be able to attain high scores, preferred college acceptance and laudable
employment.96 The status quo may become harder to overcome for those who
do not have access to the procedure.
3. Gender/Sex Selection
Of the three categories of nontherapeutic PGD uses to benefit future
children, selection based on gender/sex traits has received the most debate.97
Using PGD for sex selection originated out of the desire to create children who
lacked an X chromosome linked disease.98 Once it was determined that the
procedure could be used to select embryos on the basis of sex, potential parents
began inquiring into its use for non-medical purposes.99 In 2002, a California
woman, who already had three sons, used PGD to select a girl.100 The mother
said that she loved her sons, but longed to recreate the intimacy that she
enjoyed with her own mother.101 This is a valid wish, but it may be that the
daughter is unable to fulfill the mother’s desire for a healthy mother-daughter
relationship. Not all mothers and daughters enjoy each other’s company.
This has raised the dilemma of balancing a parent’s procreative freedom to
choose a male or female child against the larger societal concern regarding
gender stereotypes and equality. “Sex selection is sex discrimination, and I
don’t think that is ethical,” said Dr. James Grifo of the Society for Assisted
Reproductive Technology.102 In contrast, at a lecture, Dr. Joe Leigh Simpson,
Chairman of the Department of Obstetrics and Gynecology at Baylor
University said, “I would submit that gender selection is really not an issue

96. How is this prediction any different form the social divide that exists now? The wealthy
already have an advantage in being able to afford the best schools and academic prep course for
their children. The thousand dollar fee to enroll a child in an ACT, SAT, MCAT or LSAT prep
course may be out of reach for many families, leading to lower scores in students who could not
afford to take the classes. Furthermore, the cost of tuition for higher education also makes it
harder for the less financially secure to overcome the status quo.
97. Since a gene has not been found that relates to homosexuality, the focus has mainly been
on the consequences of using PGD to select the gender of future children.
98. See Rachel E. Remaley, “The Original Sexist Sin:” Regulating Preconception Selection
Technology, 10 HEALTH MATRIX 249, 253 (2000) (“To summarize, certain diseases cannot be
genetically detected, but are linked to a sex chromosome in such a way that only boys of the
prospective parents in question can be affected.”).
99. Id. (“PGD for non-therapeutic purposes is quickly becoming a reality.”).
100. See Zitner, supra note 26.
101. Id.
102. Gina Kolata, Fertility Ethics Authority Approves Sex Selection, N.Y. TIMES, Sept. 28,
2001, at A16.
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. . . . Basically, common sense will reign. I think the public is too
sophisticated to succumb to any slippery-slope uses of this technology.”103
While it is true that PGD has not been proven to be used in the United
States to overwhelmingly select one gender over another, Dr. Simpson must be
unaware of, or ignoring the popular use of, ARTs for sex selection in other
countries.104 In India and China, other methods of sex selection (ultrasounds,
abortion and infanticide) are used to attain a preferred male child.105 If nothing
is to stop parents in other countries from slippery-slope use of ART
technology, is it not possible that it will happen in the United States? Both
India and China have banned prenatal tests used to determine the sex of a fetus,
and India’s law may also apply to preconception methods.106 However, illegal
use of ARTs for sex selection still occurs in those countries.
Without any regulation of PGD for nontherapeutic purposes in the United
States, many turn to the American Society for Reproductive Medicine (ASRM)
for guidance on such issues.107 ASRM has fluctuated in its views. In 1999,
ASRM said that selecting embryos on the basis of sex should be
discouraged.108 “The initiation of IVF with PGD solely for sex selection holds
even greater risk of unwarranted gender bias, social harm, and the diversion of
medical resources from genuine medical need.”109 However, in 2001 the
acting head of ASRM’s ethics committee, John Robertson, said it would be
acceptable to use PGD for selection under the same conditions as those
outlined for sperm sorting.110 Those conditions are: (1) the couple is fully
informed of the risk of failure; (2) they affirm that they will accept children of
the opposite sex if the selection method does not work; (3) they are counseled
about having unrealistic expectations about the behavior of children of a
particular gender; and (4) they are offered the opportunity to participate in

103. Am. Soc. Of Reprod. Med., 57th Annual Meeting of the American Society of
Reproductive Medicine, DAILY NEWS (2000), available at http://asrm.online-daily.com/day3/
Day3story1.htm (It is interesting to note that the majority of the speakers at the meeting were
male.).
104. Bonnie Stienbock, Sex Selection: Not Obviously Wrong, 32 no.1 HASTINGS CTR. REP.,
23, 26 (2002).
105. Id.
106. Id.
107. See generally John Robertson, Sex Selection: Final Word from the ASRM Ethics
Committee on the Use of PGD, 32 no.2 HASTINGS CTR. REP. 6 (2002).
108. Ethics Committee of the Am. Soc. of Reprod. Med., Sex Selection and Preimplantation
Genetic Diagnosis, 72 ETHICS COMMITTEE REP., FERTILITY AND STERILITY, 861, 863-64 (May
2001) available at http://www.asrm.org/Media/Ethics/Sex_Selection.pdf.
109. Id.
110. See Stienbock, supra note 104, at 25.
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research tracking the safety and efficacy of the selection process.111 Reversing
the reversal, in 2002 Mr. Robertson said that upon additional review such uses
of PGD “should be discouraged” even when parents only want to use the
procedure to add gender variety to the existing family.112 Ultimately, in
January of 2002, the ASRM committee found that there is a difference between
preconception sex selection, like sperm sorting, and PGD embryo sex
selection.113 Embryos created through IVF, unlike sperm, are accorded
“special respect.”114 Since embryos are given a special respect above that of
sperm or eggs, ASRM has asserted that using PGD for sex selection alone
cannot be justified because embryos would be discarded merely because they
were the “wrong” sex. “[T]he committee concluded that the interest in
choosing the gender of offspring had not yet been shown to be strong enough
to justify the creation and destruction of embryos solely for gender variety in a
family.”115

111. Ethics Committee of the Am. Soc. for Reprod. Med., Preconception Gender Selection
for Nonmedical Reasons, 75 ETHICS COMMITTEE REP., FERTILITY AND STERILITY, 861, 863-64
(May 2001) available at http://www.asrm.org/Media/Ethics/preconceptiongender.pdf.
112. See Gina Kolata, Fertility Society Opposes Choosing Embryos Just for Selection, N.Y.
TIMES, Feb. 16, 2002, at A16.
113. See Robertson, supra note 107.
114. AFS Publication, Vol. 46, No. 3, at 29S
Embryos deserve respect greater than accorded to human tissue, but not the respect
accorded to actual persons. The [embryo] is due greater respect than any other human
tissue because of its potential to become a person and because of its symbolic meaning for
many people. Yet, it should not be treated as a person, because it has not yet developed
the features of personhood, is not yet established as developmentally individual, and may
never realize its biological potential.
115. Robertson, supra note 107.
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IV. PROPOSED REGULATION OF PGD
In England, PGD is authorized on a case-by-case basis as prescribed by the
Human Fertilisation and Embryology Act of 1990 (HEFA).116 In Germany,
PGD and embryo screening has been outlawed by the federal government.117
The United States has not passed any federal laws specifically regulating the
technology, but some state statutes may prohibit the use of PGD.118
If any legislation in the United States is proposed, a balance must be struck
between advancing disease prevention and guarding against the objectification
of children. Although HEFA seeks to control any misuse of PGD on a caseby-case basis, it may actually inhibit disease prevention.119 In Germany, use of
PGD is barred completely.120 There, the Embryo Protection Law protects
embryos from “improper use” and guards against improper use of reproduction
technologies.121 Also, the Federal Physicians Chamber provides guidelines for
the conditions of IVF use in Germany, preventing the procedure for any use
other than infertility.122 Since PGD is used to benefit children and not infertile
couples, the guidelines prohibit the procedure.
The United States should not follow Germany’s lead, but instead enact
federal regulations similar to England’s – with a few modifications. While
physicians should exercise caution in implementing PGD, the procedure
should remain available to families for certain reasons. Parents should be able
to use PGD to prevent serious disease in future children, but not to select
embryos on the basis of superficial traits such as physical characteristics,
performance ability, or gender. Further debate and dialogue is needed to
116. See generally Human Fertilisation and Embryology Act, 1990, c. 37, §§ 11-13, sched. 2
(Eng.) available at http://www.legislation.hmso.gov.uk/acts/acts1990/Ukpga_19900037_en
_1.htm (last visited June 8, 2003).
117. See Stephan Mueller, Ethics and the Regulation of Preimplantation Diagnosis in
Germany, 7 EUBIOS J. OF ASIAN AND INT’L BIOETHICS, 5, 5-6 (1997) available at
http://www.biol.tsukuba.ac.jp/~macer/EJ71/EJ71D.html; Dorothy Wertz, Germany Reconsiders
Preimplantation Diagnosis Ban, GENELETTER, (Apr. 1, 2001), at http://www.geneletter.org/0401-01/features/germany.html; see Zitner, supra note 26 (“In Germany, the federal government
has barred embryo screening for any purpose.”).
118. See LA. REV. STAT. ANN. § 9:124 (West 1991) (This statute declares embryos to be
“judicial person which shall not be intentionally destroyed.”). In the PGD process, most embryos
found to be affected by disease are discarded and destroyed. The statute makes it impossible to
discard any embryo, even those known to be affected by disease. Therefore, parents in Louisiana
may have to forgo PGD or pay for the continuous storage of embryos affected by disease.
119. See Couple’s “Designer Baby” Plea Denied, UK NEWSQUEST REGIONAL PRESS, Aug.
2, 2002 (A couple whose son suffered from Diamond Blackfan anaemia was denied the use of
PGD to provide him with a bone marrow donor.); see also Six Couples “Want Designer Babies,”
BBC NEWS, Feb. 24, 2002 at http://news.bbc.co.uk/1/hi/health/1839071.stm.
120. See Wertz, supra note 117.
121. See Mueller, supra note 117, at 5.
122. Id.
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determine if legislation is required to prevent parents from using PGD to create
a genetic condition or disability in a future child. While parents have the right
to carry a pregnancy to term when a defect is detected in the fetus through
CVS or amniocentesis, it is questionable whether they should be able to
intentionally create disease in a future child using PGD. Strict protocols
should also be instituted for situations in which PGD is used to create a donor
match for an existing ill child. In this case, parents should be screened for a
desire to have more children, informed of the success rates and counseled on
the problems that they may encounter in raising a donor child. These
precautions will ensure that PGD remains available to help prevent and treat
disease while guarding against the objectification of children.
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